KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Chemed (CHE) over the last 4 years, with Q4 2012 value amounting to $18.9 million.

  • Chemed's Shares Outstanding (Weighted Average) fell 779.13% to $18.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was $18.9 million, marking a year-over-year decrease of 779.13%. This contributed to the annual value of $18.9 million for FY2012, which is 779.13% down from last year.
  • Per Chemed's latest filing, its Shares Outstanding (Weighted Average) stood at $18.9 million for Q4 2012, which was down 779.13% from $19.0 million recorded in Q2 2012.
  • Chemed's Shares Outstanding (Weighted Average)'s 5-year high stood at $22.6 million during Q2 2010, with a 5-year trough of $18.9 million in Q4 2012.
  • Moreover, its 4-year median value for Shares Outstanding (Weighted Average) was $21.8 million (2009), whereas its average is $21.3 million.
  • Per our database at Business Quant, Chemed's Shares Outstanding (Weighted Average) surged by 101.26% in 2010 and then tumbled by 1002.6% in 2012.
  • Chemed's Shares Outstanding (Weighted Average) (Quarter) stood at $22.5 million in 2009, then grew by 0.61% to $22.6 million in 2010, then dropped by 9.14% to $20.5 million in 2011, then dropped by 7.79% to $18.9 million in 2012.
  • Its Shares Outstanding (Weighted Average) stands at $18.9 million for Q4 2012, versus $19.0 million for Q2 2012 and $19.0 million for Q1 2012.